Wolpert Associates, Inc. (“WAI”, d/b/a Wolpert Advisors in the state of New York), is a strategic transaction advisory firm serving the life sciences community. Mr. Jan Wolpert is the principal owner and executive of his eponymous firm. Conducting business through WAI since 2010, Mr. Wolpert has advised a roster of international companies on strategic transaction initiatives cutting across a multiplicity of therapeutic areas – e.g., oncology, neuroscience, cardio-metabolic, infectious disease disorders, etc. – primarily involving biopharmaceutical therapeutics, and in select instances, medical devices, healthcare services and other life science sectors. WAI’s perspective is unique in focusing on the intersection between scientific innovation, characteristics of global and regional medical markets, overall corporate development, and value creation – all themes that are particularly sensitive to well-conceived strategic transaction initiatives (co-development partnering alliances, licensing and M&A). WAI operates within a global platform, offering great facility working with either clients or transaction initiatives within the US, EU, India, Japan and China.